Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.65 |
| ▸ | CCR5 | P51681 | 2/20 | 0.65 |
| ▸ | CCR8 | P51685 | 2/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.47 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.39 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29943121 | 1.00 | CCR1 (0.65) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL29387096 | 0.88 | CCR1 (0.42) | CCR1CCR5CCR8CYP2A6ALDH1A1 | |
| SCHEMBL730405 | 0.88 | CCR1 (0.42) | CCR1CCR5CCR8CYP2A6ALDH1A1 | |
| SCHEMBL28023670 | 0.87 | CCR1 (0.50) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL30259554 | 0.86 | CCR1 (0.41) | CCR1CCR5CCR8CYP2A6ALDH1A1 | |
| SCHEMBL30259309 | 0.86 | CCR1 (0.41) | CCR1CCR5CCR8CYP2A6ALDH1A1 | |
| SCHEMBL7217946 | 0.84 | CCR1 (0.71) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL7217944 | 0.84 | CCR1 (0.71) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL25282590 | 0.81 | KDM1A (0.43) | CCR1CCR5CCR8CYP2A6ALDH1A1 | |
| SCHEMBL7236054 | 0.81 | CCR1 (0.55) | CCR1CCR5CCR8CYP2A6METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636366-B2 | Ruthenium (II) complexes and conjugates thereof for use as photosensitizer agent in photodynamic therapy | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE PARIS (FR) | 2026-05-26 | — | — | US | disclosed |
| CN-116162113-A | Bipyridine ruthenium complex with photodynamic therapy effect, and preparation method and application thereof | 南通大学 | 2023-05-26 | — | — | CN | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| CN-115894572-A | Terpyridyl ruthenium complex and preparation method and application thereof | 南通大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115850348-A | Biquinoline/bipyridine ruthenium complex and preparation method and application thereof | 南通大学 | 2023-03-28 | — | — | CN | disclosed |
| EP-4079740-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | I-SENS, INC. (KR) | 2022-10-26 | — | — | EP | disclosed |
| US-20220296711-A1 | Ruthenium (II) Complexes and Conjugates Thereof for Use as Photosensitizer Agent in Photodynamic Therapy | UNIVERSITY OF ZÜRICH (CH) | 2022-09-22 | — | — | US | disclosed |
| US-11214586-B2 | Rhodamine triplet state complex and preparation and photodynamic therapy (PDT) study thereof | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2022-01-04 | — | — | US | disclosed |
| US-11214586-B2 | Rhodamine triplet state complex and preparation and photodynamic therapy (PDT) study thereof | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2022-01-04 | — | — | US | disclosed |
| US-20100130733-A1 | LUMINESCENT METAL ION COMPLEXES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2010-05-27 | — | — | US | disclosed |
| US-20100130733-A1 | LUMINESCENT METAL ION COMPLEXES | BIOSEARCH TECHNOLOGIES, INC. (US) | 2010-05-27 | — | — | US | disclosed |
| US-7635762-B2 | Luminescent metal ion complexes | BIOSEARCH TECHNOLOGIES, INC. (US) | 2009-12-22 | — | — | US | disclosed |
| US-7635762-B2 | Luminescent metal ion complexes | BIOSEARCH TECHNOLOGIES, INC. (US) | 2009-12-22 | — | — | US | disclosed |
| WO-2009140573-A1 | COLLAGEN PEPTIDE CONJUGATES AND USES THEREFOR | PURDUE RESEARCH FOUNDATION (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2003055477-A1 | METHOD FOR THE TREATMENT OF MC RECEPTOR RELATED DISORDERS WITH A CHELATE AND/OR A CHELATOR | 7TM PHARMA A/S (DK) | 2003-07-10 | — | — | WO | disclosed |
| WO-2003003009-A1 | USE OF METAL-ION CHELATES IN VALIDATING BIOLOGICAL MOLECULES AS DRUG TARGETS IN TEST ANIMAL MODELS | 7TM PHARMA A/S (DK) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003003008-A1 | CHEMICAL LIBRARIES USEFUL FOR DRUG DISCOVERY PROCESSES | 7TM PHARMA A/S (DK) | 2003-01-09 | — | — | WO | disclosed |
| US-20020177695-A1 | Nucleic acid probes and methods | DUKE UNIVERSITY | 2002-11-28 | — | — | US | disclosed |
| US-6288221-B1 | REPLACING NUCLEOSIDE WITH DIMETHOXYTRITYL, PHOSPHORAMIDITE, OR HALONUCLEOSIDE DERIVATIVE; ELECTROCHEMICAL OR PHOTOCHEMICAL DETECTION OF NUCLEIC ACID SEQUENCES | DUKE UNIVERSITY | 2001-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296711-A1 | Ruthenium (II) Complexes and Conjugates Thereof for Use as Photosensitizer Agent in Photodynamic Therapy | ANXA5, CD47, SPR | CCR1 3484/4885CCR5 1969/4885CCR8 4073/4885 |
| US-11214586-B2 | Rhodamine triplet state complex and preparation and photodynamic therapy (PDT) study thereof | MT-CO1, MT-CO3, MT-CO2 | CCR1 4726/4885CCR5 4866/4885CCR8 4718/4885 |
| US-12636366-B2 | Ruthenium (II) complexes and conjugates thereof for use as photosensitizer agent in photodynamic therapy | FABP2, APC, TP53 | CCR1 1967/4885CCR5 1492/4885CCR8 1892/4885 |
| US-20100130733-A1 | LUMINESCENT METAL ION COMPLEXES | SLC30A6, SLC39A14, SLC39A3 | CCR1 3924/4885CCR5 2756/4885CCR8 4032/4885 |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | MB, CACYBP, SPR | CCR1 1590/4885CCR5 884/4885CCR8 647/4885 |
| US-20020177695-A1 | Nucleic acid probes and methods | NUDT1, NT5C3B, NT5C2 | CCR1 3566/4885CCR5 1372/4885CCR8 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.